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Abstract Fibrin deposition is au integral feature of the inflammatory response. In response to C-reactive protein (CRP), an acute-phase reactant, 
blood monocytes ynthesize and express tissue factor (TF), the main initiator of blood coagulation. We report the inhibitory effect of interleukin 
10 (IL-IO) and that of pentoxifylline, a methyl xanthine derivative, on monocyte expression of TF activity, TF protein and TF mRNA iu response 
to CRP. These agents may be of use in diseases where a TF-induced prothrombotic state is detrimental. 
Key words: Monocyte; Tissue factor; C-reactive protein; Interleukin-10; Pentoxifylline 
1. Introduction 
Activation of human blood monocytes by a variety of proin- 
flammatory agents induces these cells to synthesize and express 
on their surface tissue factor (TF), a transmembrane glycopro- 
tein which is the main initiator of blood coagulation [l]. The 
role of this aberrant TF expression in triggering excessive acti- 
vation of coagulation and both extravascular and intravascular 
fibrin deposition is now well established in a number of immu- 
nological and non-immunological inflammatory diseases [2]. 
C-reactive protein (CRP), an acute-phase reactant, the con- 
centration of which can increase from trace levels to several 
hundred ,uglml within 24 h, has recently been shown to trigger 
TF synthesis by monocytes [3]. This effect is probably mediated 
through the binding of CRP to specific monocytic receptors [4] 
and involves TF mRNA production [3]. 
The aim of this work was to assess the effect of interleukin-10 
(IL-lo) and that of pcntoxifylline @‘TX), a methylxanthine 
derivative [1-(5-oxo-hexyl)-3,7_dimethylxanthine] (Torental, 
Hoechst), on CRP-induced TF activity, TF antigen and mRNA 
expression. These two compounds have been shown to down- 
regulate LPS-induced TF synthesis [5,6] and have great poten- 
tial therapeutic value. 
2. Materials and methods 
Mononuclear cell suspensions containing 20-30% monocytes and 
70-80% lymphocytes were isolated by Ficoll-Hypaque gradient sedi- 
mentation as described in [7]. To obtain monocyte-enriched prepara- 
tions (75-95%), monocytes were further purified by adherence to gela- 
tinffibronectin-coated Petri dishes [8]. Cell suspensions or adherent 
monocytes were incubated with or without IL-10 or PTX for 30 min 
at 37”C, before stimulation with 25 &ml CRP (Sigma, St. Louis) for 
l-8 h. Incubation was performed with 5% CO,, in RPM1 medium 
without foetal calf serum but otherwise supplemented as described in 
[6]. Because of slight contamination of CRP with LPS, the incubation 
medium was routinely supplemented with 5 &ml polymyxin B (Sigma, 
St Louis). We checked that, under these conditions, the effect of LPS 
was completely neutralized (data not shown). Purified human H-10 
was generously provided by DNAX (Palo Alto, CA, USA). After iucu- 
bation, the supemataut was discarded and cells were washed and stored 
for less than 1 week at -80°C until TF measurement of RNA extrac- 
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tion. Siuce monocytes are the only circulating cells to produce TF, 
mononuclear cell suspsensions were used to measure TF activity and 
TF antigen levels; adherent monocytes were used for RNA extraction; 
TF activity was also measured in the latter. 
After thawing, cells were lysed and TF activity was assayed as de- 
scribed in [7,8]. Procoagulant activity (PCA) was expressed as TF mU/ 
lo6 monocytes. To determine what proportion of PCA was TF-initi- 
ated, PCA was measured in some experiments after incubation of the 
cell lysate for 30 min with a neutralizing monoclonal antibody to human 
TF (MoAb4; Corvas, San Diego, CA). 
Total RNA was extracted by the guauidinium-thiocyanate/cesium 
chloride method [8]. Aliquots (5 pg) were applied to slots on a micro- 
sample filtration manifold and transferred onto nitrocelhrlose mem- 
branes. Filters were hybridized for 24 h at 42’C, to the TF and G3PDH 
cDNA probes consecutively. The autoradiograms were scanned by 
means of laser densitometry, using the Sebia Preference R apparatus, 
to determine relative levels of mRNA in treated and untreated mon- 
ocytes. 
cDNA probes were labeled with [ccg2P]dCTP (300 CYmmol) by ran- 
dom hexamer primer extension, using the Amersham Multiprime kit. 
The 641 bp TF cDNA probe, kindly provided by T.S. Edgington [9], 
was excised from plasmid pUC8 with EcoRI. The G3PDH probe was 
purchased from Clontech (Palo Alto, CA). 
TF antigen was determined by au ELISA method using the Imubind 
TF kit (American Diagnostica Inc., Greenwich) according to manufac- 
turer’s instructions, with slight modifications. Cells were solubilized in 
PBS containing 1% Triton X-100 and directly transferred to the ELISA 
plate. 
3. Results and discussion 
As already shown [3], incubation of freshly isolated moncytes 
with increasing CRP concentrations (2.5-50 &ml) for 7 h led 
to a concentration-dependent increase in TF activity, from 130 
to 1600 mu/lo6 monocytes (Fig. 1, inset). Procoagnlant activity 
was identified as TF, as more than 97% was inhibited when cells 
were incubated with a neutralizing monoclonal antibody to TF. 
We then investigated the effect of graded concentrations of 
IL-10 and F’TX on CRP-induced TF activity. As shown in 
Fig. 1, both agents had a concentration-dependent inhibitory 
effect which reached 80% of the CRP-induced effect; IC,, val- 
ues were about 5 U/ml IL-10 and 90 PM PTX. The effects of 
IL-10 and PTX on CRP-induced TF protein expression were 
then analyzed by means of ELISA: treatment with 25 &ml 
of CRP produced the expected induction of TF expression 
from 22.5 (cells without CRP) to 368 pg/106 monocytes. With 
increasing concentrations of IL-10 or PTX, TF activity and 
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Fig. 1. Effects of IL-IO and PTX on TF activity produced in response 
to CRP in human monocytes. The effect of increasing concentrations 
of CRP on TF activity of mononuclear cells is shown in the inset. 
Mononuclear cell suspensions were preincubated for 30 min with 
graded concentrations of IL-10 (A) or PTX (B) and subsequently stim- 
ulated with 25 &ml CRP. Results are means f S.E.M. of four separate 
experiments. 
antigen levels measured in the same experiments (n = 2) correlated 
strongly (I = 0.95; P < 0.01) (Fig. 2). Moreover, the measured 
ICY,, values were similar regardless of which TF assay was used. 
As recently stated by McGee et al. [lo], three theoretical 
mechanisms could be involved in modulating membrane TF 
activity, namely changes in lipid membrane cofactor, de novo 
synthesis of TF pathway inhibitor (TFPI), the main TF inhibi- 
tor, and changes in TF protein levels. Our results suggest hat 
the inhibitory effect of PTX and IL-10 on CRP-induced TF 
activity is mainly, if not exclusively, secondary to a decrease in 
membrane TF protein expression. 
The time-course of the induction of TF activity by CRP was 
then studied (Fig. 3). Monocytes were incubated with 25 pg/ml 
CRP and, after a lag time of 3 h, TF activity rapidly increased 
between the 4th and 8th hour; PTX and IL-10 inhibited this 
increase as early as the fourth hour, and continued to do so at 
6 and 8 h. 
We then studied the effect of IL-10 and PTX on CRP-in- 
duced TF mRNA levels. As shown in Fig. 4,25 pg/ml of CRP 
Fig. 2. Correlation between TF activity and TF antigen expression of 
CRP-exposed monocytes in the presence of increasing concentrations 
of IL-10 (1, 10,50,100 U/ml) or PTX (50,100,250,500~M) (r = 0.95, 
P < 0.001; y = 1.01.x + 1.57). Results are the percentage of maximal TF 
expression induced by CRP (25 @ml) in the absence of inhibitor. 
induced a tenfold increase in TF mRNA relative to untreated 
cells. The CRP-induced increase in TF mRNA was completely 
abolished when cells were preincubated with 50 U/ml IL-10 or 
250 PM PTX, suggesting that the decrease in TF protein levels 
was secondary to a decrease in TF mRNA expression. 
Monocytes and macrophages are present in inflammatory 
lesions. Expression of TF activity is believed to be an important 
factor in the thromboembolic manifestations often associated 
with intlammatory diseases uch as lupus erythematosus [l 11, 
Crohn’s disease [12], post-operative conditions [13] and infec- 
tious diseases [141. The role of inflammation in unstable angina 
has been recently underlined by Liuzzo et al. [ 151 who cofirmed 
the elevation of CRP in these patients at the time of admission; 
they also showed the prognostic value of CRI? the 20 patients 
who had levels of CRP 2 0.3 mg/dl had more ischemic episodes 
in the hospital than those with levels < 0.3 mg/dl. Unstable 
angina has also been reported to be associated with an increase 
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Fig. 3. Kinetics of the inhibition by IL-10 and PTX of CRP-induced 
expression of TF activity from 0 to 8 h. Mononuclear cells were incu- 
bated for 0, 1, 2, 3, 4, 6 and 8 h with RPM1 medium alone, CRP, 
CRP + IL-IO, or CRP + PTX. 
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Fig. 4. Slot blot analysis of TF mRNA. 5 pg of total RNA was ana- 
lyzed. RNA was extracted from untreated monocytes (RPMI; 1) and 
from cells exposed for 8 h to 25&ml CRP (2), CRP + IL-10 at 50 U/ml 
(3) or CRP + PTX 250 PM (4). The membrane was hybridized to TF 
and G3PDH probes. Signal intensity was measured by means of laser 
densitometry and is expressed relative to the G3PDH control. 
in monocyte TF activity [16,171. As previously suggested [3,13], 
monocyte stimulation by CRP could be one of the mechanisms 
involved in TF expression. In view of the deleterious effect of 
TF expression, down-regulation of its expression by admini- 
stration of IL-10 or PTX could be of great clinical value. Re- 
cently, both agents have been shown to down-regulate TF ex- 
pression efficiently in animal models of endotoxemia. It was not 
determined whether they acted directly on LPS-induced TF 
production or indirectly by decreasing levels of tumor necrosis 
factor, another TF inducer. Our in vitro results suggest hat 
PTX and IL-10 could also be useful in the prevention of throm- 
bosis and extravascular fibrin deposition associated with in- 
flammatory diseases. 
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